Akorn Latanoprost Ophthalmic Solution Recall: Risk of Contamination
Akorn recalls certain lots of Latanoprost eye drops due to potential contamination. The product may be empty, under-filled, or leaking, posing a risk of infection. Affected patients should contact Akorn for instructions.
Use caution until it’s fixed
Lack of assurance of sterility: product was found to be empty, under-filled, or leaking.
Contact the company
What happened, in plain English
Akorn is recalling specific lots of Latanoprost eye drops (0.005%) that may be empty, under-filled, or leaking. This could lead to eye infections if used. Consumers should stop using these products and contact Akorn for guidance. Read more at govinfonow.com/recall/41808-akorn-latanoprost-ophthalmic-solution-recall-risk-of-contamination.
Source Summary by GovInfoNow · govinfonow.com/recall/41808-akorn-latanoprost-ophthalmic-solution-recall-risk-of-contamination · Updated October 8, 2026 · FDA enforcement record: FDA #D-0661-2017
Cite this page
“Akorn Latanoprost Ophthalmic Solution Recall: Risk of Contamination.” GovInfoNow, updated October 8, 2026. https://govinfonow.com/recall/41808-akorn-latanoprost-ophthalmic-solution-recall-risk-of-contamination. Based on FDA recall #D-0661-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0661-2017%22&limit=1).
Why it’s dangerous
The product may be empty, under-filled, or leaking, which can introduce contaminants into the eye. This increases the risk of infection, especially if the solution is not properly sterile.
Who’s affected
People with prescriptions for Latanoprost eye drops from the affected lots. Those with compromised immune systems or existing eye conditions are at higher risk.
How to tell if you have this one
Check the product label for the lot numbers: LAB15G52, LAB11G52, LAB18I52, LAB9L52, LAB1A62, or LAB9A62. The expiration dates are June 2017, August 2017, or November 2017.
- Brand
Akorn- Category
Drug
What to do — step by step
Check Product Label
Look for the lot numbers: LAB15G52, LAB11G52, LAB18I52, LAB9L52, LAB1A62, or LAB9A62.
Contact Akorn
Reach out to Akorn directly for instructions on how to handle the recalled product.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2.3 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0661-2017 (March 17, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0661-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 8, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.